News from daiichi sankyo, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 18, 2016, 10:31 ET Daiichi Sankyo, Inc. To Establish New U.S. Headquarters in Basking Ridge, New Jersey

 Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Company, Ltd., today announced that it will establish a new U.S. headquarters,...


Apr 01, 2016, 09:00 ET Daiichi Sankyo Announces Appointment of Antoine Yver, MD, MSc to Global Head, Oncology Research and Development

 Daiichi Sankyo, Inc. today announced the appointment of Antoine Yver, MD, MSc, to Global Head, Oncology Research and Development, effective...


Nov 10, 2015, 16:11 ET Daiichi Sankyo and Plexxikon Announce FDA Approval of Cobimetinib in Combination with Zelboraf® (vemurafenib) in Advanced Melanoma

 Daiichi Sankyo, Inc. and Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced the U.S. Food and Drug Administration (FDA)...


Oct 30, 2015, 11:23 ET FDA Grants Breakthrough Therapy Designation for Daiichi Sankyo and Plexxikon's Investigational CSF-1R Inhibitor Pexidartinib (PLX3397) in Tenosynovial Giant Cell Tumor

 Daiichi Sankyo, Inc. and Plexxikon Inc., a member of the Daiichi Sankyo Group, today announced that the U.S. Food and Drug Administration...


Oct 16, 2015, 11:11 ET Daiichi Sankyo, Inc. Reorganizes its U.S. Commercial Operations to Support Upcoming Specialty Pipeline

Daiichi Sankyo, Inc. ("the Company") announced today that it will reorganize its U.S. Commercial organization as it begins to transition from a...


Jul 29, 2015, 17:00 ET Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients

Daiichi Sankyo, Inc. and Plexxikon Inc., a member of the Daiichi Sankyo Group, announced today that The New England Journal of Medicine (NEJM)...


Apr 01, 2015, 08:00 ET Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge

 Daiichi Sankyo, Inc., the US subsidiary of Daiichi Sankyo Company, Ltd, announced today that it will merge with its US-based sister company,...


Mar 19, 2015, 06:00 ET Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US

 Daiichi Sankyo, Inc. today announced a co-commercialization agreement with AstraZeneca for MOVANTIK™ (naloxegol) in the US, in line with...


Jan 09, 2015, 10:09 ET Daiichi Sankyo, Inc. Announces Civil Settlement

Daiichi Sankyo, Inc. ("the Company") announced today that it has reached a civil settlement with the U.S. Government, as...


Dec 04, 2014, 16:40 ET Ambit Biosciences and Daiichi Sankyo, Inc. Announce Two Oral Presentations And One Poster Highlighting Quizartinib To Be Presented At The 56th Annual Meeting Of The American Society Of Hematology (ASH)

Ambit Biosciences, a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and...


Aug 06, 2014, 19:00 ET Daiichi Sankyo and Charleston Laboratories Announce Collaboration to Develop and Commercialize Novel, Fixed-Dose Combination Hydrocodone Products for Pain and Opioid-Induced Nausea and Vomiting (OINV) in the US

Daiichi Sankyo and Charleston Laboratories, Inc., through its wholly owned subsidiary LOCL Pharma, Inc., announced today that the parties have...


Apr 18, 2014, 09:00 ET Ken Keller Named President, US Commercial, Daiichi Sankyo, Inc.

 Daiichi Sankyo, Inc. announced today that Ken Keller will join the company as President of its Commercial operations in the United States...


Jan 08, 2014, 08:30 ET Daiichi Sankyo, Virtici and Celdara Medical Announce Collaboration to Identify and Progress High Potential Therapeutics

Daiichi Sankyo, Co., Ltd., Virtici, LLC and Celdara Medical, LLC announced today that they have entered into a collaboration to jointly...


Oct 03, 2013, 16:00 ET Daiichi Sankyo, Inc. Makes Two New Executive Appointments

 Daiichi Sankyo, Inc. today announced that Glenn Gormley, MD, PhD, has been named corporate President and Chairman of Daiichi Sankyo, Inc....


Jun 06, 2013, 08:00 ET New Guidelines From the American Association of Clinical Endocrinologists (AACE) Identify Welchol® (colesevelam HCI) for Lowering Both A1C and LDL-Cholesterol in Patients with Type 2 Diabetes

Recent guidance from the American Association of Clinical Endocrinologists (AACE) highlight for the first time a cardiovascular risk factor...


Mar 27, 2012, 10:30 ET Centennial Tree Planting Ceremony Commemorates Philanthropy, Collaboration and Friendship

Today, chief executives from Daiichi Sankyo joined the National Cherry Blossom Festival and American and Japanese dignitaries in Washington,...


Mar 09, 2012, 08:00 ET Chef Becker Announces Franklin's Family Fixin's Contest Winner

Chef Franklin Becker of the Two Reasons, One Recipe campaign is pleased to name Lorin Cook of Alpine, N.J. the grand prize winner of the Franklin's...


Oct 21, 2011, 11:45 ET Daiichi Sankyo, Inc. Brings the Legacy of Washington, DC Cherry Trees to New Jersey

Approximately 100 cherry tree saplings were planted in Central Park of Morris County today, the newest park in the Morris County Park System,...


Sep 08, 2011, 10:00 ET Renowned Chef Launches "Franklin's Family Fixin's" Offering Adults with Type 2 Diabetes and/or High Cholesterol a Healthy "Fix" to Traditional Family Recipes

Some of the most enjoyable family moments are spent over a meal. Whether it's a celebration, or a typical weeknight dinner, your favorite family...


Aug 17, 2011, 09:59 ET FDA Approval of Zelboraf™ (vemurafenib) Establishes Oncology Foothold in US for Daiichi Sankyo

With the US Food and Drug Administration (FDA) approval today of Zelboraf™ (vemurafenib), a first-in-class personalized treatment for...


Aug 17, 2011, 08:30 ET Daiichi Sankyo, Inc. Appoints Executive Vice President of Drug Development for the Americas

Daiichi Sankyo, Inc. announced that Mahmoud Ghazzi, MD, PhD has joined Daiichi Sankyo Pharma Development (DSPD) as its new executive vice president...


Jul 25, 2011, 12:36 ET Once-Daily Welchol® (colesevelam HCl) for Oral Suspension Receives FDA Approval To be Mixed With Fruit Juice or Diet Soft Drinks

Daiichi Sankyo, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for...


Jun 28, 2011, 10:04 ET Daiichi Sankyo, Inc. Names Danesha Dixon Smith Vice President of Human Resources

Daiichi Sankyo, Inc. (DSI) announced today that Danesha Dixon Smith has joined the company as its Vice President of Human Resources. "Hiring and...


May 23, 2011, 08:00 ET Study Finds Long-Term Treatment with TRIBENZOR™ was Effective and Well-Tolerated Regardless of Age, Race, or Diabetes Status

Data evaluating the long-term efficacy and safety of olmesartan medoxomil, amlodipine besylate, plus hydrochlorothiazide (OM/AML + HCTZ) in...


May 20, 2011, 08:30 ET Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students

During a 'Day of Science,' more than 30 middle school students from Newark Science Park High School experienced what it was like to be scientists...